1 - 25 of 26 results for author:"Brown R.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. Kang S.H., Abdel-Massih R.C., Brown R.A., Dierkhising R.A., Kremers W.K., Razonable R.R. J. Infect. Dis. 205:639-646(2012) · Mapped (2) |
| Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Lee S.O., Brown R.A., Kang S.H., Abdel-Massih R.C., Razonable R.R. Liver Transpl. 17:1081-1088(2011) · Mapped (2) |
| Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. El-Helou O., Berbari E.F., Brown R.A., Gralewski J.H., Osmon D.R., Razonable R.R. Hum. Immunol. 72:47-53(2011) · Mapped (2) |
| Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Leventhal A.M., David S.P., Brightman M., Strong D., McGeary J.E., Brown R.A., Lloyd-Richardson E.E., Munafo M., Uhl G.R., Niaura R. Pharmacogenomics J. 12:86-92(2012) · Mapped (56) |
| The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat. King V.R., Hewazy D., Alovskaya A., Phillips J.B., Brown R.A., Priestley J.V. Neuroscience 168:523-530(2010) · Mapped (5) |
| R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Brown R.A., Gralewski J.H., Eid A.J., Knoll B.M., Finberg R.W., Razonable R.R. Transplantation 89:811-815(2010) · Mapped (4) |
| The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Brown R.A., Gralewski J.H., Razonable R.R. Clin. Infect. Dis. 49:e96-9(2009) · Mapped (2) |
| Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Old W.M., Shabb J.B., Houel S., Wang H., Couts K.L., Yen C.Y., Litman E.S., Croy C.H., Meyer-Arendt K., Miranda J.G. et al. |
| Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. David S.P., Strong D.R., Munafo M.R., Brown R.A., Lloyd-Richardson E.E., Wileyto P.E., Evins E.A., Shields P.G., Lerman C., Niaura R. Nicotine Tob. Res. 9:1251-1257(2007) · Mapped (6) |
| Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lonnqvist J., Huttunen M.O. et al. Proc. Natl. Acad. Sci. U.S.A. 104:18280-18285(2007) · Mapped (1) |
| Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Brown R.A., Clarke G.W., Ledbetter C.L., Hurle M.J., Denyer J.C., Simcock D.E., Coote J.E., Savage T.J., Murdoch R.D., Page C.P. et al. Eur. Respir. J. 31:311-319(2008) · Mapped (2) |
| Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Transplantation 84:511-516(2007) · Mapped (2) |
| Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. David S.P., Brown R.A., Papandonatos G.D., Kahler C.W., Lloyd-Richardson E.E., Munafo M.R., Shields P.G., Lerman C., Strong D., McCaffery J. et al. Nicotine Tob. Res. 9:821-833(2007) · Mapped (12) |
| Neuronal competition and selection during memory formation. Han J.H., Kushner S.A., Yiu A.P., Cole C.J., Matynia A., Brown R.A., Neve R.L., Guzowski J.F., Silva A.J., Josselyn S.A. Science 316:457-460(2007) · Mapped (11) |
| Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Kijpittayarit S., Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Clin. Infect. Dis. 44:1315-1320(2007) · Mapped (2) |
| Toll-like receptor-2 Arg753Gln polymorphism and herpes virus infections in transplantation. Eid A.J., Brown R.A., Razonable R.R. Transplantation 82:1383-1385(2006) · Mapped (2) |
| The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Li W., Cui Y., Kushner S.A., Brown R.A., Jentsch J.D., Frankland P.W., Cannon T.D., Silva A.J. Curr. Biol. 15:1961-1967(2005) · Mapped (5) |
| The effects of treatment with antibodies to transforming growth factor beta1 and beta2 following spinal cord damage in the adult rat. King V.R., Phillips J.B., Brown R.A., Priestley J.V. Neuroscience 126:173-183(2004) · Mapped (6) |
| Interleukin-18 promotes sleep in rabbits and rats. Kubota T., Fang J., Brown R.A., Krueger J.M. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R828-38(2001) · Mapped (5) |
| Insulin activates the alpha isoform of class II phosphoinositide 3-kinase. Brown R.A., Domin J., Arcaro A., Waterfield M.D., Shepherd P.R. J. Biol. Chem. 274:14529-14532(1999) · UniProtKB (1) |
| cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K-C2gamma, and chromosomal assignment of this gene (PIK3C2G) to 12p12. Rozycka M., Lu Y.-J., Brown R.A., Lau M.R., Shipley J.M., Fry M.J. Genomics 54:569-574(1998) · UniProtKB (1) |
| Identification of four novel human phosphoinositide 3-kinases defines a multi-isoform subfamily. Ho L.K., Liu D., Rozycka M., Brown R.A., Fry M.J. Biochem. Biophys. Res. Commun. 235:130-137(1997) · UniProtKB (1) |
| Identification and cDNA cloning of a novel mammalian C2 domain-containing phosphoinositide 3-kinase, HsC2-PI3K. Brown R.A., Ho L.K.F., Weber-Hall S.J., Shipley J.M., Fry M.J. Biochem. Biophys. Res. Commun. 233:537-544(1997) · UniProtKB (1) |
| Crystal structures of a single coiled-coil peptide in two oligomeric states reveal the basis for structural polymorphism. Gonzalez L. Jr., Brown R.A., Richardson D., Alber T. Nat. Struct. Biol. 3:1002-1009(1996) · Mapped (1) |
| Isocitrate dehydrogenases from Haloferax volcanii and Sulfolobus solfataricus: enzyme purification, characterisation and N-terminal sequence. Camacho M.L., Brown R.A., Bonete M.J., Danson M.J., Hough D.W. FEMS Microbiol. Lett. 134:85-90(1995) · UniProtKB (1) |